Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -89.48% vs 5.82% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -94.15% vs 7.43% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 6.06% vs 0.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Vicore Pharma Holding AB With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -52.94% vs 88.89% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 1.65% vs -3.50% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -89.48% vs 5.82% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -3.85% vs -21.52% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -94.15% vs 7.43% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -75.86% vs -45.08% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 6.06% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






